Antiviral agent comprising CD4 and H2 histone

PCT No. PCT/GB93/00934 Sec. 371 Date Dec. 30, 1994 Sec. 102(e) Date Dec. 30, 1994 PCT Filed May 6, 1993 PCT Pub. No. WO93/21943 PCT Pub. Date Nov. 11, 1993The invention provides an agent against HIV and/or related viruses, comprising CD4 or a CD4-like substance and an H2 histone or an H2 histone-lik...

Full description

Saved in:
Bibliographic Details
Main Authors EDWARDS; ROBERT JOHN, GOODERHAM; NIGEL JOHN, DAVIES; DONALD SELWYN, SHAUNAK; SUNIL
Format Patent
LanguageEnglish
Published 03.02.1998
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/GB93/00934 Sec. 371 Date Dec. 30, 1994 Sec. 102(e) Date Dec. 30, 1994 PCT Filed May 6, 1993 PCT Pub. No. WO93/21943 PCT Pub. Date Nov. 11, 1993The invention provides an agent against HIV and/or related viruses, comprising CD4 or a CD4-like substance and an H2 histone or an H2 histone-like protein. The content of the CD4 or CD4-like substance is preferably less than the antivirally effective dose of that substance alone. The invention also provides an H2 histone or an H2-like protein, for use in a method of medical treatment, in particular against HIV and/or related viruses, and also for use in the manufacture of a pharmaceutical composition against HIV and/or related viruses.
Bibliography:Application Number: US19940335740